-
Comirnaty recommended for 5-11 year olds in the EU
Comirnaty recommended for 5-11 year olds in the EU
-
Comirnaty recommended for 5-11 year olds in the EU
Comirnaty recommended for 5-11 year olds in the EU
EMA has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11
-
Report on sales of antimicrobials for animal use
Report on sales of antimicrobials for animal use
-
Report on sales of antimicrobials for animal use
Report on sales of antimicrobials for animal use
The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) report shows more than 40% decrease in sales of antimicrobials for animal use between 2011-2020
-
EMA evaluates COVID-19 Vaccine Janssen booster
EMA evaluates COVID-19 Vaccine Janssen booster
-
EMA evaluates COVID-19 Vaccine Janssen booster
EMA evaluates COVID-19 Vaccine Janssen booster
EMA starts evaluating an application for the use of a booster dose of COVID-19 Vaccine Janssen to be given at least two months after the first dose to people aged 18 years and older
-
EMA webinar for SMEs and academia
EMA webinar for SMEs and academia
-
EMA webinar for SMEs and academia
EMA webinar for SMEs and academia
On 29 November, EMA will hold a webinar to inform academics and small and medium-sized enterprises about the Clinical Trials Regulation and the Clinical Trials Information System.
